SuperworthDogwood Therapeutics market cap DWTX
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $38.1M
- Highest close in our data
- $1.8B
- Sep 2022
Dogwood Therapeutics is worth $38.1M at the close on Oct 23, 2026, at $1.12 a share.
That is up 239% over the last year and down 96% over five years.
Its highest close in our data was $1.8B in Sep 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $38.1M | $6.4M | $100.2M | +308% |
| 2025 | $9.3M | $2.5M | $16.6M | +148% |
| 2024 | $3.8M | $3.1M | $390.4M | −99% |
| 2023 | $276.9M | $121.5M | $1.1B | +156% |
| 2022 | $108.1M | $57.3M | $1.8B | −90% |
| 2021 | $1.1B | $895.5M | $1.4B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Dogwood Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| DWTXDogwood Therapeutics | $38.1M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $69M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Dogwood Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.